 |
FDA Approval Activities for this Drug
Zetia (ezetimibe) Tablets, 10 mg, MSP Singapore Company, NDA 21-445 Vytorin (ezetimibe/simvastatin) Tablets, MSP Singapore Company, Approval Zetia (ezetimibe) Tablets, MSP Singapore Co., Labeling Revision | Zetia (ezetimibe) Tablets, Schering Corporation, Labeling Revision | Vytorin (ezetimibe/simvastatin) Tablets, Merck & Co., Inc., Package Change | Zetia (ezetimibe) Tablets, Schering Corp., Labeling Revision | Vytorin (ezetimibe/simvastatin) Tablets, Merck & Co., Labeling Revision | Zetia (ezetimibe) Tablets, Schering Corporation, Labeling Revision | Vytorin (ezetimibe/simvastatin) Tablets, Merck & Co., Labeling Revision | Vytorin (ezetimibe/simvastatin) Tablets, Merck & Co., Labeling Revision | Vytorin (ezetimibe/simvastatin) Tablets, Merck & Co., Control Supplement | Zetia (ezetimibe) Tablets, Schering Corp., Labeling Revision | Vytorin (ezetimibe/simvastatin) Tablets, Merck & Co., Comparative Efficacy | Zetia (ezetimibe) Tablets, Schering Corp., Efficacy Supp. w/Clinical Data & Labeling Revision | Zetia (ezetimibe) Tablets, Schering Corp., New or Modified Indication | Vytorin (ezetimibe/simvastatin) Tablets, Merck & Co., Labeling Revision | Vytorin (ezetimibe/simvastatin) Tablets, Merck & Co., Comparative Efficacy Claim | Vytorin (ezetimibe/simvastatin) Tablets, Merck & Co., Labeling Revision | Zetia (ezetimibe) Tablets, Schering Corp., Labeling Revision | Vytorin (ezetimibe/simvastatin) Tablets, MSP Singapore Co. LLC., Manufacturing Change or Addition | Vytorin (ezetimibe/simvastatin) Tablets, MSP Singapore, Labeling Revision | Vytorin (ezetimibe/simvastatin) Tablets, Merck & Co., Labeling Revision | Zetia (Ezetimibe) Tablets, Schering Corp., Labeling Revision | Vytorin (ezetimibe/simvastatin) Tablets, Merck & Co., Labeling Revision | Zetia (Ezetimibe) Tablets, Schering Corp., Labeling Revision | Zetia (ezetimibe) Tablets, MSP Singapore Co., LLC, Labeling Revision | Zetia (ezetimibe) Tablets, MSP Singapore Co., LLC, Patient Population Altered| Vytorin (ezetimibe and simvastatin) Tablets, MSP Singapore Company, LLC, Labeling Revision | Vytorin (ezetimibe and simvastatin) Tablets, MSP Singapore Company, LLC, Labeling Revision | Zetia (ezetimibe) Tablets, MSP Singapore Co., LLC, Package Change | Vytorin (ezetimibe and simvastatin) Tablets, MSP Singapore Co., LLC, Approval | Ezetimibe Tablets, Glenmark Generics Limited, Tentative Approval | Zetia (ezetimibe) Tablets, MSP Singapore Co., LLC, Labeling Revision | Vytorin (ezetimibe/simvastatin) Tablets, MSP Singapore Company, LLC, Labeling Revision | Vytorin (ezetimibe and simvastatin) Tablets, MSP Singapore Company, LLC., Labeling Revision | Vytorin (ezetimibe and simvastatin) Tablets, MSP Singapore Co., Labeling Revision | Vytorin (ezetimibe and simvastatin) Tablets, MSP Singapore Co., LLC, Labeling Revision | Zetia (ezetimibe) Tablets, MSP Singapore Co., LLC, Labeling Revision | Ezetimibe and Simvastatin Tablets, Mylan Pharmaceuticals Inc., Tentative Approval | Vytorin (ezetimibe and simvastatin) Tablets, MSP Singapore Co., LLC, Labeling Revision | Vytorin (ezetimibe and simvastatin) Tablets, MSD International, Labeling Revision | Zetia, ezetimibe, Tablet; Oral, Msp Singapore, Efficacy Supplement with Clinical Data to Support
| Vytorin, ezetimibe; simvastatin, Tablet; Oral, Msd Intl, Efficacy Supplement with Clinical Data to Support
^ FDA's latest approval appears at the bottom of this list. ^
|